Is a complete ARTV research report available?

No complete published report is available for Artiva Biotherapeutics, Inc. (ARTV) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Artiva Biotherapeutics, Inc. (ARTV)

NASDAQ: ARTV · USD

$10.0

-0.10 (-1.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ARTV analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	487.3M
Net income (ttm)	-87.1M
EPS (ttm)	-$3.55
Shares out	48.6M
Volume	567,954
Beta	2.19
Price target	$35.8	+256.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -87.1M
EPS (ttm): -$3.55
Market cap: 487.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ARTV indicators

Market & fundamental data

Available fields

180

Groups with data

Currency

USD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001817241
Company name	Artiva Biotherapeutics, Inc.
Country	United States
Country code	US
Cusip	04317A107
Employees	106
Employees Change	2%
Employees Change Percent	1.92
Enterprise value	$410.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2024-07-19
Isin	US04317A1079
Last refreshed	2026-07-25
Market cap	$487.3M
Market cap category	Small-Cap
Price	$10.03
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	2836
Symbol	ARTV
Website	https://www.artivabio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-17.87%
FCF yield	-16.45%
P/B ratio	2.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-87.1M
Net Income Growth Years	0%
Profit Per Employee	$-821,415
ROA	-38.72
Roa5y	-26.78
ROCE	-96.84
ROE	-67.86
Roe5y	-62.5
ROIC	-40.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	212.71%
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$106M
Cash	$86.8M
Current Assets	$88.7M
Current Liabilities	$10.9M
Debt	$10.3M
Debt Equity	$0.12
Equity	$87.8M
Liabilities	$18.1M
Long Term Assets	$17.2M
Long Term Liabilities	$7.2M
Net Cash	$76.5M
Net Cash By Market Cap	$15.7
Net Cash Growth	-49.65%
Net Debt Equity	$-0.87
Tangible Book Value	$87.8M
Tangible Book Value Per Share	$3.55
WACC	15.97

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.16
Net Working Capital	$-5.9M
Quick ratio	8.03
Working Capital	$77.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-43.09%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	212.46%
200-day SMA	6.3
50-day SMA	8.88
50-day SMA vs 200-day SMA	50over200
All Time High	17.31
All Time High Change	-42.06%
All Time High Date	2024-10-01
All Time Low	1.47
All Time Low Change	582.31%
All Time Low Date	2025-06-27
ATR	0.94
Beta	2.19
Beta1y	6.02
Beta2y	2.27
Ch YTD	133.8
High	11.3
High52	14.53
High52 Date	2026-04-20
High52ch	-30.97%
Low	9.74
Low52	2.22
Low52 Date	2025-09-17
Low52ch	351.8%
Ma50ch	12.9%
Premarket Change Percent	3.65
Premarket Price	$10.5
Premarket Volume	21,851
Price vs 200-day SMA	59.28%
RSI	55.8
RSI Monthly	52.85
RSI Weekly	60.81
Sharpe ratio	1.29x
Sortino ratio	3.21
Total Return	-43.09%
Tr YTD	133.8
Tr1m	2.35%
Tr1w	2.77%
Tr3m	-11.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	4
Analyst Price Target Top	$40.33
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.64
Operating Income	$-92.1M
Price target	$35.8
Price Target Change	$257
Price Target Change Top	$302

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,684,632%
Float Percent	40.51%
Net Borrowing	-132,000
Shares Insiders	4.45%
Shares Institutions	14.55%
Shares Out	48,588,198
Shares Qo Q	0.43%
Shares Yo Y	43.09%
Short Float	6.81%
Short Ratio	1.9
Short Shares	2.76

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-86.5M
Average Volume	476,681.05x
Bv Per Share	3.55
CAPEX	$-2.3M
Ch1m	2.35
Ch1w	2.77
Ch1y	212.5
Ch3m	-11.24
Ch6m	109.8
Change	-0.99%
Change From Open	-4.66
Close	10.13
Days Gap	3.85
Depreciation Amortization	2,635,000
Dollar Volume	5,696,578.6
Earnings Date	2026-08-06
Earnings Time	amc
EBIT	$-92.1M
EBITDA	$-89.4M
EPS	$-3.55
F Score	1
FCF	$-80.2M
FCF EV Yield	-19.52x
FCF Per Share	$-1.65
Financing CF	-342,000
Fiscal Year End	December
Founded	2,019
Investing CF	68,756,000
Ipr	-16.42
Iprfo	-37.31
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-10
Ma150	7.16
Ma150ch	40.18%
Ma20	9.6
Ma20ch	4.52%
Net CF	-9,446,000
Next Earnings Date	2026-08-05
Open	10.52
Optionable	No
Position In Range	18.59
Post Close	10.03
Postmarket Change Percent	-0.3
Postmarket Price	$10
Ppne	16,296,000
Pre Close	10.13
Price Date	2026-07-24
Ptbv Ratio	5.55
Relative Volume	1.19x
Share Based Comp	6,362,000
Tr6m	109.83%
Us State	California
Volume	567,954

Artiva Biotherapeutics, Inc. (ARTV)

Coverage state: Market snapshot only — no published research

Generate the first ARTV analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ARTV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ARTV indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ARTV

Frequently asked questions